nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolcapone—CYP2C9—Ifosfamide—testicular cancer	0.0436	0.673	CbGbCtD
Tolcapone—CYP2C9—Cisplatin—testicular cancer	0.0212	0.327	CbGbCtD
Tolcapone—Sweating—Epirubicin—testicular cancer	0.00065	0.000695	CcSEcCtD
Tolcapone—Pollakiuria—Doxorubicin—testicular cancer	0.00065	0.000695	CcSEcCtD
Tolcapone—Haematuria—Epirubicin—testicular cancer	0.000647	0.000692	CcSEcCtD
Tolcapone—Dizziness—Ifosfamide—testicular cancer	0.000646	0.000691	CcSEcCtD
Tolcapone—Pharyngitis—Methotrexate—testicular cancer	0.000646	0.000691	CcSEcCtD
Tolcapone—Urinary tract disorder—Methotrexate—testicular cancer	0.000643	0.000687	CcSEcCtD
Tolcapone—Epistaxis—Epirubicin—testicular cancer	0.00064	0.000684	CcSEcCtD
Tolcapone—Urethral disorder—Methotrexate—testicular cancer	0.000638	0.000682	CcSEcCtD
Tolcapone—Weight decreased—Doxorubicin—testicular cancer	0.000637	0.000681	CcSEcCtD
Tolcapone—Sinusitis—Epirubicin—testicular cancer	0.000636	0.00068	CcSEcCtD
Tolcapone—Feeling abnormal—Etoposide—testicular cancer	0.000636	0.00068	CcSEcCtD
Tolcapone—Nausea—Dactinomycin—testicular cancer	0.000633	0.000677	CcSEcCtD
Tolcapone—Pneumonia—Doxorubicin—testicular cancer	0.000631	0.000675	CcSEcCtD
Tolcapone—Gastrointestinal pain—Etoposide—testicular cancer	0.000631	0.000675	CcSEcCtD
Tolcapone—Infestation NOS—Doxorubicin—testicular cancer	0.000628	0.000671	CcSEcCtD
Tolcapone—Infestation—Doxorubicin—testicular cancer	0.000628	0.000671	CcSEcCtD
Tolcapone—Vomiting—Ifosfamide—testicular cancer	0.000621	0.000664	CcSEcCtD
Tolcapone—Hypersensitivity—Cisplatin—testicular cancer	0.000621	0.000664	CcSEcCtD
Tolcapone—Bradycardia—Epirubicin—testicular cancer	0.00062	0.000663	CcSEcCtD
Tolcapone—Rash—Ifosfamide—testicular cancer	0.000616	0.000659	CcSEcCtD
Tolcapone—Dermatitis—Ifosfamide—testicular cancer	0.000616	0.000658	CcSEcCtD
Tolcapone—Erythema multiforme—Methotrexate—testicular cancer	0.000615	0.000658	CcSEcCtD
Tolcapone—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000615	0.000658	CcSEcCtD
Tolcapone—Urticaria—Etoposide—testicular cancer	0.000613	0.000656	CcSEcCtD
Tolcapone—Haemoglobin—Epirubicin—testicular cancer	0.000612	0.000654	CcSEcCtD
Tolcapone—Stomatitis—Doxorubicin—testicular cancer	0.000612	0.000654	CcSEcCtD
Tolcapone—Rhinitis—Epirubicin—testicular cancer	0.00061	0.000653	CcSEcCtD
Tolcapone—Body temperature increased—Etoposide—testicular cancer	0.00061	0.000652	CcSEcCtD
Tolcapone—Abdominal pain—Etoposide—testicular cancer	0.00061	0.000652	CcSEcCtD
Tolcapone—Urinary tract infection—Doxorubicin—testicular cancer	0.00061	0.000652	CcSEcCtD
Tolcapone—Haemorrhage—Epirubicin—testicular cancer	0.000609	0.000651	CcSEcCtD
Tolcapone—Tinnitus—Methotrexate—testicular cancer	0.000607	0.000649	CcSEcCtD
Tolcapone—Hypoaesthesia—Epirubicin—testicular cancer	0.000606	0.000648	CcSEcCtD
Tolcapone—Asthenia—Cisplatin—testicular cancer	0.000604	0.000646	CcSEcCtD
Tolcapone—Pharyngitis—Epirubicin—testicular cancer	0.000604	0.000646	CcSEcCtD
Tolcapone—Sweating—Doxorubicin—testicular cancer	0.000602	0.000643	CcSEcCtD
Tolcapone—Urinary tract disorder—Epirubicin—testicular cancer	0.000601	0.000643	CcSEcCtD
Tolcapone—Oedema peripheral—Epirubicin—testicular cancer	0.0006	0.000641	CcSEcCtD
Tolcapone—Haematuria—Doxorubicin—testicular cancer	0.000598	0.00064	CcSEcCtD
Tolcapone—Urethral disorder—Epirubicin—testicular cancer	0.000597	0.000638	CcSEcCtD
Tolcapone—Epistaxis—Doxorubicin—testicular cancer	0.000592	0.000633	CcSEcCtD
Tolcapone—Angiopathy—Methotrexate—testicular cancer	0.00059	0.000631	CcSEcCtD
Tolcapone—Sinusitis—Doxorubicin—testicular cancer	0.000589	0.00063	CcSEcCtD
Tolcapone—Mediastinal disorder—Methotrexate—testicular cancer	0.000586	0.000627	CcSEcCtD
Tolcapone—Chills—Methotrexate—testicular cancer	0.000584	0.000624	CcSEcCtD
Tolcapone—Nausea—Ifosfamide—testicular cancer	0.00058	0.000621	CcSEcCtD
Tolcapone—Diarrhoea—Cisplatin—testicular cancer	0.000576	0.000616	CcSEcCtD
Tolcapone—Erythema multiforme—Epirubicin—testicular cancer	0.000576	0.000616	CcSEcCtD
Tolcapone—Alopecia—Methotrexate—testicular cancer	0.000575	0.000615	CcSEcCtD
Tolcapone—Bradycardia—Doxorubicin—testicular cancer	0.000574	0.000613	CcSEcCtD
Tolcapone—Mental disorder—Methotrexate—testicular cancer	0.00057	0.00061	CcSEcCtD
Tolcapone—Hypersensitivity—Etoposide—testicular cancer	0.000569	0.000608	CcSEcCtD
Tolcapone—Tinnitus—Epirubicin—testicular cancer	0.000568	0.000607	CcSEcCtD
Tolcapone—Haemoglobin—Doxorubicin—testicular cancer	0.000566	0.000606	CcSEcCtD
Tolcapone—Rhinitis—Doxorubicin—testicular cancer	0.000565	0.000604	CcSEcCtD
Tolcapone—Haemorrhage—Doxorubicin—testicular cancer	0.000563	0.000602	CcSEcCtD
Tolcapone—Hypoaesthesia—Doxorubicin—testicular cancer	0.000561	0.000599	CcSEcCtD
Tolcapone—Pharyngitis—Doxorubicin—testicular cancer	0.000559	0.000598	CcSEcCtD
Tolcapone—Urinary tract disorder—Doxorubicin—testicular cancer	0.000556	0.000595	CcSEcCtD
Tolcapone—Oedema peripheral—Doxorubicin—testicular cancer	0.000555	0.000593	CcSEcCtD
Tolcapone—Dysgeusia—Methotrexate—testicular cancer	0.000555	0.000593	CcSEcCtD
Tolcapone—Asthenia—Etoposide—testicular cancer	0.000554	0.000592	CcSEcCtD
Tolcapone—Angiopathy—Epirubicin—testicular cancer	0.000552	0.000591	CcSEcCtD
Tolcapone—Urethral disorder—Doxorubicin—testicular cancer	0.000552	0.000591	CcSEcCtD
Tolcapone—Mediastinal disorder—Epirubicin—testicular cancer	0.000549	0.000587	CcSEcCtD
Tolcapone—Chills—Epirubicin—testicular cancer	0.000546	0.000584	CcSEcCtD
Tolcapone—Pruritus—Etoposide—testicular cancer	0.000546	0.000584	CcSEcCtD
Tolcapone—Arrhythmia—Epirubicin—testicular cancer	0.000544	0.000582	CcSEcCtD
Tolcapone—Alopecia—Epirubicin—testicular cancer	0.000538	0.000575	CcSEcCtD
Tolcapone—Vomiting—Cisplatin—testicular cancer	0.000536	0.000573	CcSEcCtD
Tolcapone—Vision blurred—Methotrexate—testicular cancer	0.000534	0.000571	CcSEcCtD
Tolcapone—Mental disorder—Epirubicin—testicular cancer	0.000533	0.00057	CcSEcCtD
Tolcapone—Erythema multiforme—Doxorubicin—testicular cancer	0.000533	0.00057	CcSEcCtD
Tolcapone—Rash—Cisplatin—testicular cancer	0.000531	0.000568	CcSEcCtD
Tolcapone—Dermatitis—Cisplatin—testicular cancer	0.000531	0.000567	CcSEcCtD
Tolcapone—Diarrhoea—Etoposide—testicular cancer	0.000528	0.000565	CcSEcCtD
Tolcapone—Ill-defined disorder—Methotrexate—testicular cancer	0.000526	0.000562	CcSEcCtD
Tolcapone—Tinnitus—Doxorubicin—testicular cancer	0.000525	0.000562	CcSEcCtD
Tolcapone—Anaemia—Methotrexate—testicular cancer	0.000524	0.00056	CcSEcCtD
Tolcapone—Flatulence—Epirubicin—testicular cancer	0.000522	0.000559	CcSEcCtD
Tolcapone—Tension—Epirubicin—testicular cancer	0.00052	0.000556	CcSEcCtD
Tolcapone—Dysgeusia—Epirubicin—testicular cancer	0.000519	0.000555	CcSEcCtD
Tolcapone—Nervousness—Epirubicin—testicular cancer	0.000515	0.00055	CcSEcCtD
Tolcapone—Angiopathy—Doxorubicin—testicular cancer	0.000511	0.000547	CcSEcCtD
Tolcapone—Malaise—Methotrexate—testicular cancer	0.000511	0.000546	CcSEcCtD
Tolcapone—Dizziness—Etoposide—testicular cancer	0.00051	0.000546	CcSEcCtD
Tolcapone—Muscle spasms—Epirubicin—testicular cancer	0.00051	0.000545	CcSEcCtD
Tolcapone—Vertigo—Methotrexate—testicular cancer	0.000509	0.000544	CcSEcCtD
Tolcapone—Mediastinal disorder—Doxorubicin—testicular cancer	0.000508	0.000543	CcSEcCtD
Tolcapone—Chills—Doxorubicin—testicular cancer	0.000506	0.000541	CcSEcCtD
Tolcapone—Arrhythmia—Doxorubicin—testicular cancer	0.000503	0.000538	CcSEcCtD
Tolcapone—Nausea—Cisplatin—testicular cancer	0.0005	0.000535	CcSEcCtD
Tolcapone—Vision blurred—Epirubicin—testicular cancer	0.0005	0.000534	CcSEcCtD
Tolcapone—Alopecia—Doxorubicin—testicular cancer	0.000498	0.000532	CcSEcCtD
Tolcapone—Cough—Methotrexate—testicular cancer	0.000494	0.000529	CcSEcCtD
Tolcapone—Mental disorder—Doxorubicin—testicular cancer	0.000494	0.000528	CcSEcCtD
Tolcapone—Ill-defined disorder—Epirubicin—testicular cancer	0.000492	0.000526	CcSEcCtD
Tolcapone—Vomiting—Etoposide—testicular cancer	0.000491	0.000525	CcSEcCtD
Tolcapone—Anaemia—Epirubicin—testicular cancer	0.00049	0.000524	CcSEcCtD
Tolcapone—Agitation—Epirubicin—testicular cancer	0.000487	0.000521	CcSEcCtD
Tolcapone—Rash—Etoposide—testicular cancer	0.000487	0.00052	CcSEcCtD
Tolcapone—Dermatitis—Etoposide—testicular cancer	0.000486	0.00052	CcSEcCtD
Tolcapone—Headache—Etoposide—testicular cancer	0.000483	0.000517	CcSEcCtD
Tolcapone—Flatulence—Doxorubicin—testicular cancer	0.000483	0.000517	CcSEcCtD
Tolcapone—Arthralgia—Methotrexate—testicular cancer	0.000482	0.000516	CcSEcCtD
Tolcapone—Chest pain—Methotrexate—testicular cancer	0.000482	0.000516	CcSEcCtD
Tolcapone—Myalgia—Methotrexate—testicular cancer	0.000482	0.000516	CcSEcCtD
Tolcapone—Tension—Doxorubicin—testicular cancer	0.000481	0.000515	CcSEcCtD
Tolcapone—Dysgeusia—Doxorubicin—testicular cancer	0.00048	0.000514	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000479	0.000512	CcSEcCtD
Tolcapone—Malaise—Epirubicin—testicular cancer	0.000478	0.000511	CcSEcCtD
Tolcapone—Discomfort—Methotrexate—testicular cancer	0.000476	0.000509	CcSEcCtD
Tolcapone—Nervousness—Doxorubicin—testicular cancer	0.000476	0.000509	CcSEcCtD
Tolcapone—Vertigo—Epirubicin—testicular cancer	0.000476	0.000509	CcSEcCtD
Tolcapone—Syncope—Epirubicin—testicular cancer	0.000475	0.000508	CcSEcCtD
Tolcapone—Muscle spasms—Doxorubicin—testicular cancer	0.000472	0.000504	CcSEcCtD
Tolcapone—Palpitations—Epirubicin—testicular cancer	0.000468	0.000501	CcSEcCtD
Tolcapone—Confusional state—Methotrexate—testicular cancer	0.000466	0.000498	CcSEcCtD
Tolcapone—Loss of consciousness—Epirubicin—testicular cancer	0.000466	0.000498	CcSEcCtD
Tolcapone—Cough—Epirubicin—testicular cancer	0.000463	0.000495	CcSEcCtD
Tolcapone—Vision blurred—Doxorubicin—testicular cancer	0.000462	0.000494	CcSEcCtD
Tolcapone—Infection—Methotrexate—testicular cancer	0.000459	0.000491	CcSEcCtD
Tolcapone—Nausea—Etoposide—testicular cancer	0.000458	0.00049	CcSEcCtD
Tolcapone—Hypertension—Epirubicin—testicular cancer	0.000458	0.000489	CcSEcCtD
Tolcapone—Ill-defined disorder—Doxorubicin—testicular cancer	0.000455	0.000487	CcSEcCtD
Tolcapone—Nervous system disorder—Methotrexate—testicular cancer	0.000453	0.000485	CcSEcCtD
Tolcapone—Anaemia—Doxorubicin—testicular cancer	0.000453	0.000485	CcSEcCtD
Tolcapone—Thrombocytopenia—Methotrexate—testicular cancer	0.000453	0.000484	CcSEcCtD
Tolcapone—Myalgia—Epirubicin—testicular cancer	0.000451	0.000483	CcSEcCtD
Tolcapone—Chest pain—Epirubicin—testicular cancer	0.000451	0.000483	CcSEcCtD
Tolcapone—Arthralgia—Epirubicin—testicular cancer	0.000451	0.000483	CcSEcCtD
Tolcapone—Agitation—Doxorubicin—testicular cancer	0.000451	0.000482	CcSEcCtD
Tolcapone—Anxiety—Epirubicin—testicular cancer	0.00045	0.000481	CcSEcCtD
Tolcapone—Skin disorder—Methotrexate—testicular cancer	0.000449	0.00048	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000448	0.000479	CcSEcCtD
Tolcapone—Hyperhidrosis—Methotrexate—testicular cancer	0.000447	0.000478	CcSEcCtD
Tolcapone—Discomfort—Epirubicin—testicular cancer	0.000446	0.000477	CcSEcCtD
Tolcapone—Malaise—Doxorubicin—testicular cancer	0.000442	0.000473	CcSEcCtD
Tolcapone—Dry mouth—Epirubicin—testicular cancer	0.000441	0.000472	CcSEcCtD
Tolcapone—Vertigo—Doxorubicin—testicular cancer	0.000441	0.000471	CcSEcCtD
Tolcapone—Anorexia—Methotrexate—testicular cancer	0.000441	0.000471	CcSEcCtD
Tolcapone—Syncope—Doxorubicin—testicular cancer	0.00044	0.00047	CcSEcCtD
Tolcapone—Confusional state—Epirubicin—testicular cancer	0.000436	0.000466	CcSEcCtD
Tolcapone—Palpitations—Doxorubicin—testicular cancer	0.000433	0.000463	CcSEcCtD
Tolcapone—Oedema—Epirubicin—testicular cancer	0.000433	0.000463	CcSEcCtD
Tolcapone—Hypotension—Methotrexate—testicular cancer	0.000432	0.000462	CcSEcCtD
Tolcapone—Loss of consciousness—Doxorubicin—testicular cancer	0.000431	0.000461	CcSEcCtD
Tolcapone—Infection—Epirubicin—testicular cancer	0.00043	0.00046	CcSEcCtD
Tolcapone—Cough—Doxorubicin—testicular cancer	0.000428	0.000458	CcSEcCtD
Tolcapone—Shock—Epirubicin—testicular cancer	0.000426	0.000455	CcSEcCtD
Tolcapone—Nervous system disorder—Epirubicin—testicular cancer	0.000424	0.000454	CcSEcCtD
Tolcapone—Thrombocytopenia—Epirubicin—testicular cancer	0.000424	0.000453	CcSEcCtD
Tolcapone—Hypertension—Doxorubicin—testicular cancer	0.000423	0.000453	CcSEcCtD
Tolcapone—Tachycardia—Epirubicin—testicular cancer	0.000422	0.000451	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000421	0.00045	CcSEcCtD
Tolcapone—Skin disorder—Epirubicin—testicular cancer	0.00042	0.000449	CcSEcCtD
Tolcapone—Hyperhidrosis—Epirubicin—testicular cancer	0.000418	0.000447	CcSEcCtD
Tolcapone—Myalgia—Doxorubicin—testicular cancer	0.000418	0.000446	CcSEcCtD
Tolcapone—Chest pain—Doxorubicin—testicular cancer	0.000418	0.000446	CcSEcCtD
Tolcapone—Arthralgia—Doxorubicin—testicular cancer	0.000418	0.000446	CcSEcCtD
Tolcapone—Anxiety—Doxorubicin—testicular cancer	0.000416	0.000445	CcSEcCtD
Tolcapone—Paraesthesia—Methotrexate—testicular cancer	0.000415	0.000444	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000415	0.000443	CcSEcCtD
Tolcapone—Discomfort—Doxorubicin—testicular cancer	0.000413	0.000441	CcSEcCtD
Tolcapone—Anorexia—Epirubicin—testicular cancer	0.000412	0.000441	CcSEcCtD
Tolcapone—Dyspnoea—Methotrexate—testicular cancer	0.000412	0.000441	CcSEcCtD
Tolcapone—Somnolence—Methotrexate—testicular cancer	0.000411	0.000439	CcSEcCtD
Tolcapone—Dry mouth—Doxorubicin—testicular cancer	0.000408	0.000437	CcSEcCtD
Tolcapone—Dyspepsia—Methotrexate—testicular cancer	0.000407	0.000435	CcSEcCtD
Tolcapone—Hypotension—Epirubicin—testicular cancer	0.000404	0.000432	CcSEcCtD
Tolcapone—Confusional state—Doxorubicin—testicular cancer	0.000404	0.000432	CcSEcCtD
Tolcapone—Decreased appetite—Methotrexate—testicular cancer	0.000402	0.00043	CcSEcCtD
Tolcapone—Oedema—Doxorubicin—testicular cancer	0.0004	0.000428	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000399	0.000427	CcSEcCtD
Tolcapone—Fatigue—Methotrexate—testicular cancer	0.000399	0.000426	CcSEcCtD
Tolcapone—Infection—Doxorubicin—testicular cancer	0.000398	0.000425	CcSEcCtD
Tolcapone—Pain—Methotrexate—testicular cancer	0.000395	0.000423	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000394	0.000421	CcSEcCtD
Tolcapone—Shock—Doxorubicin—testicular cancer	0.000394	0.000421	CcSEcCtD
Tolcapone—Nervous system disorder—Doxorubicin—testicular cancer	0.000393	0.00042	CcSEcCtD
Tolcapone—Thrombocytopenia—Doxorubicin—testicular cancer	0.000392	0.000419	CcSEcCtD
Tolcapone—Tachycardia—Doxorubicin—testicular cancer	0.000391	0.000418	CcSEcCtD
Tolcapone—Skin disorder—Doxorubicin—testicular cancer	0.000389	0.000416	CcSEcCtD
Tolcapone—Paraesthesia—Epirubicin—testicular cancer	0.000388	0.000415	CcSEcCtD
Tolcapone—Hyperhidrosis—Doxorubicin—testicular cancer	0.000387	0.000414	CcSEcCtD
Tolcapone—Dyspnoea—Epirubicin—testicular cancer	0.000386	0.000412	CcSEcCtD
Tolcapone—Somnolence—Epirubicin—testicular cancer	0.000385	0.000411	CcSEcCtD
Tolcapone—Anorexia—Doxorubicin—testicular cancer	0.000382	0.000408	CcSEcCtD
Tolcapone—Feeling abnormal—Methotrexate—testicular cancer	0.000381	0.000407	CcSEcCtD
Tolcapone—Dyspepsia—Epirubicin—testicular cancer	0.000381	0.000407	CcSEcCtD
Tolcapone—Gastrointestinal pain—Methotrexate—testicular cancer	0.000378	0.000404	CcSEcCtD
Tolcapone—Decreased appetite—Epirubicin—testicular cancer	0.000376	0.000402	CcSEcCtD
Tolcapone—Hypotension—Doxorubicin—testicular cancer	0.000374	0.0004	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000373	0.000399	CcSEcCtD
Tolcapone—Fatigue—Epirubicin—testicular cancer	0.000373	0.000399	CcSEcCtD
Tolcapone—Pain—Epirubicin—testicular cancer	0.00037	0.000396	CcSEcCtD
Tolcapone—Constipation—Epirubicin—testicular cancer	0.00037	0.000396	CcSEcCtD
Tolcapone—Urticaria—Methotrexate—testicular cancer	0.000367	0.000393	CcSEcCtD
Tolcapone—Body temperature increased—Methotrexate—testicular cancer	0.000365	0.000391	CcSEcCtD
Tolcapone—Abdominal pain—Methotrexate—testicular cancer	0.000365	0.000391	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000365	0.00039	CcSEcCtD
Tolcapone—Paraesthesia—Doxorubicin—testicular cancer	0.000359	0.000384	CcSEcCtD
Tolcapone—Dyspnoea—Doxorubicin—testicular cancer	0.000357	0.000382	CcSEcCtD
Tolcapone—Feeling abnormal—Epirubicin—testicular cancer	0.000357	0.000381	CcSEcCtD
Tolcapone—Somnolence—Doxorubicin—testicular cancer	0.000356	0.000381	CcSEcCtD
Tolcapone—Gastrointestinal pain—Epirubicin—testicular cancer	0.000354	0.000378	CcSEcCtD
Tolcapone—Dyspepsia—Doxorubicin—testicular cancer	0.000352	0.000377	CcSEcCtD
Tolcapone—Decreased appetite—Doxorubicin—testicular cancer	0.000348	0.000372	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000346	0.00037	CcSEcCtD
Tolcapone—Fatigue—Doxorubicin—testicular cancer	0.000345	0.000369	CcSEcCtD
Tolcapone—Urticaria—Epirubicin—testicular cancer	0.000344	0.000367	CcSEcCtD
Tolcapone—Pain—Doxorubicin—testicular cancer	0.000342	0.000366	CcSEcCtD
Tolcapone—Constipation—Doxorubicin—testicular cancer	0.000342	0.000366	CcSEcCtD
Tolcapone—Abdominal pain—Epirubicin—testicular cancer	0.000342	0.000366	CcSEcCtD
Tolcapone—Body temperature increased—Epirubicin—testicular cancer	0.000342	0.000366	CcSEcCtD
Tolcapone—Hypersensitivity—Methotrexate—testicular cancer	0.000341	0.000364	CcSEcCtD
Tolcapone—Asthenia—Methotrexate—testicular cancer	0.000332	0.000355	CcSEcCtD
Tolcapone—Feeling abnormal—Doxorubicin—testicular cancer	0.00033	0.000353	CcSEcCtD
Tolcapone—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000327	0.00035	CcSEcCtD
Tolcapone—Pruritus—Methotrexate—testicular cancer	0.000327	0.00035	CcSEcCtD
Tolcapone—Hypersensitivity—Epirubicin—testicular cancer	0.000319	0.000341	CcSEcCtD
Tolcapone—Urticaria—Doxorubicin—testicular cancer	0.000318	0.00034	CcSEcCtD
Tolcapone—Abdominal pain—Doxorubicin—testicular cancer	0.000316	0.000338	CcSEcCtD
Tolcapone—Body temperature increased—Doxorubicin—testicular cancer	0.000316	0.000338	CcSEcCtD
Tolcapone—Diarrhoea—Methotrexate—testicular cancer	0.000316	0.000338	CcSEcCtD
Tolcapone—Asthenia—Epirubicin—testicular cancer	0.00031	0.000332	CcSEcCtD
Tolcapone—Pruritus—Epirubicin—testicular cancer	0.000306	0.000327	CcSEcCtD
Tolcapone—Dizziness—Methotrexate—testicular cancer	0.000306	0.000327	CcSEcCtD
Tolcapone—Diarrhoea—Epirubicin—testicular cancer	0.000296	0.000317	CcSEcCtD
Tolcapone—Hypersensitivity—Doxorubicin—testicular cancer	0.000295	0.000315	CcSEcCtD
Tolcapone—Vomiting—Methotrexate—testicular cancer	0.000294	0.000314	CcSEcCtD
Tolcapone—Rash—Methotrexate—testicular cancer	0.000291	0.000312	CcSEcCtD
Tolcapone—Dermatitis—Methotrexate—testicular cancer	0.000291	0.000311	CcSEcCtD
Tolcapone—Headache—Methotrexate—testicular cancer	0.00029	0.00031	CcSEcCtD
Tolcapone—Asthenia—Doxorubicin—testicular cancer	0.000287	0.000307	CcSEcCtD
Tolcapone—Dizziness—Epirubicin—testicular cancer	0.000286	0.000306	CcSEcCtD
Tolcapone—Pruritus—Doxorubicin—testicular cancer	0.000283	0.000303	CcSEcCtD
Tolcapone—Vomiting—Epirubicin—testicular cancer	0.000275	0.000294	CcSEcCtD
Tolcapone—Nausea—Methotrexate—testicular cancer	0.000275	0.000294	CcSEcCtD
Tolcapone—Diarrhoea—Doxorubicin—testicular cancer	0.000274	0.000293	CcSEcCtD
Tolcapone—Rash—Epirubicin—testicular cancer	0.000273	0.000292	CcSEcCtD
Tolcapone—Dermatitis—Epirubicin—testicular cancer	0.000273	0.000291	CcSEcCtD
Tolcapone—Headache—Epirubicin—testicular cancer	0.000271	0.00029	CcSEcCtD
Tolcapone—Dizziness—Doxorubicin—testicular cancer	0.000265	0.000283	CcSEcCtD
Tolcapone—Nausea—Epirubicin—testicular cancer	0.000257	0.000275	CcSEcCtD
Tolcapone—Vomiting—Doxorubicin—testicular cancer	0.000255	0.000272	CcSEcCtD
Tolcapone—Rash—Doxorubicin—testicular cancer	0.000252	0.00027	CcSEcCtD
Tolcapone—Dermatitis—Doxorubicin—testicular cancer	0.000252	0.00027	CcSEcCtD
Tolcapone—Headache—Doxorubicin—testicular cancer	0.000251	0.000268	CcSEcCtD
Tolcapone—Nausea—Doxorubicin—testicular cancer	0.000238	0.000254	CcSEcCtD
